Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03271554
Brief Title: Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea

First Submitted : September 1, 2017
First Submitted that Met QC Criteria : September 1, 2017
First Posted : September 5, 2017

Last Update Submitted that Met QC Criteria : August 16, 2019
Last Update Posted : August 19, 2019